EpCAM-specific ICE® constructs exhibited the concentration-dependent binding to EpCAM+ cell lines as shown for the HCC-1187 cells in Figure 4, whilst the CD30/CD16A ICE® control showed no binding (Figure 4 and Table 5). Here, EPCAM is linked to hepatocellular carcinoma.